EPS8 upregulates FOXM1 expression, enhancing cell growth and motility

Carcinogenesis

Volumn 31, Issue 6, 2010, Pages 1132-1141

  Wang, Huixin ^a   Teh, Muy Teck ^b   Ji, Youngmi ^c   Patel, Vyomesh ^d   Firouzabadian, Shahrzad ^a   Patel, Anisha A ^a   Gutkind, J Silvio ^d   Yeudall, W Andrew ^a,e,f  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^e Department of Biochemistry and Molecular Biology ^*  (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA B KINASE; CARRIER PROTEIN; CELL CYCLE PROTEIN 20; CYCLIN A; CYCLIN B1; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 8; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GELATINASE B; HISTONE H3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN FOXM1; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CXCL5 PROTEIN, HUMAN; EPS8 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXM1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; GENE ACTIVITY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; CELL DIVISION; CELL MOTION; CHROMATIN IMMUNOPRECIPITATION; GENETICS; METABOLISM; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL5; CHROMATIN IMMUNOPRECIPITATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UP-REGULATION;

EID: 77953957570     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq058     Document Type: Article

References (64)

1. Ozanne,B. et al. (1986) Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J. Pathol., 149, 9-14.
2. Salomon,D.S. et al. (1987) Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. J. Cell Physiol., 130, 397-409.
3. Prime,S.S. et al. (1994) Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines. Br. J. Cancer, 69, 8-15.
4. Prigent,S.A. et al. (1996) Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J. Biol. Chem., 271, 25639-25645.
5. Coso,O.A. et al. (1995) The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell, 81, 1137- 1146.
6. Minden,A. et al. (1995) Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell, 81, 1147-1157.
7. Fazioli,F. et al. (1992) Identification and biochemical characterization of novel putative substrates for the epidermal growth factor receptor kinase. J. Biol. Chem., 267, 5155-5161.
8. Kishan,K.V. et al. (1997) The SH3 domain of Eps8 exists as a novel intertwined dimer. Nat. Struct. Biol., 4, 739-743.
9. Castagnino,P. et al. (1995) Direct binding of eps8 to the juxtamembrane domain of EGFR is phosphotyrosine- and SH2-independent. Oncogene, 10, 723-729.
10. Fazioli,F. et al. (1993) Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J., 12, 3799-3808.
11. Matoskova,B. et al. (1995) Constitutive phosphorylation of eps8 in tumor cell lines: relevance to malignant transformation. Mol. Cell. Biol., 15, 3805-3812.
12. Matoskova,B. et al. (1996) RN-tre specifically binds to the SH3 domain of eps8 with high affinity and confers growth advantage to NIH3T3 upon carboxy-terminal truncation. Oncogene, 12, 2679-2688.
13. Biesova,Z. et al. (1997) Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth. Oncogene, 14, 233-241.
14. Inobe,M. et al. (1999) Identification of EPS8 as a Dvl1-associated molecule. Biochem. Biophys. Res. Commun., 266, 216-221.
15. Funato,Y. et al. (2004) IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness. Cancer Res., 64, 5237-5244.
16. Lanzetti,L. et al. (2000) The Eps8 protein coordinates EGF receptor signalling through Rac and trafficking through Rab5. Nature, 408, 374-377.
17. Scita,G. et al. (1999) EPS8 and E3B1 transduce signals from Ras to Rac. Nature, 401, 290-293.
18. Scita,G. et al. (2001) An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine. J. Cell Biol., 154, 1031-1044.
19. Disanza,A. et al. (2004) Eps8 controls actin-based motility by capping the barbed ends of actin filaments. Nat. Cell Biol., 6, 1180-1188.
20. Leu,T.H. et al. (2004) Participation of p97Eps8 in Src-mediated transformation. J. Biol. Chem., 279, 9875-9881.
21. Wang,H. et al. (2009) Role for EPS8 in squamous carcinogenesis. Carcinogenesis, 30, 165-174.
22. Yeudall,W.A. et al. (2005) Uncoupling of epidermal growth factordependent proliferation and invasion in a model of squamous carcinoma progression. Oral Oncol., 41, 698-708.
23. Kulkarni,P.S. et al. (1995) Characterization of human buccal epithelial cells transfected with the simian virus 40 T-antigen gene. Carcinogenesis, 16, 2515-2521.
24. Miyazaki,H. et al. (2006) Downregulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res., 66, 4279-4284.
25. Teh,M.T. et al. (2002) FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res., 62, 4773-4780.
26. Li,W. et al. (1999) Protein kinase C-alpha overexpression stimulates Akt activity and suppresses apoptosis induced by interleukin 3 withdrawal. Oncogene, 18, 6564-6572.
27. Keates,A.C. et al. (2001) ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial eells. J. Biol. Chem., 276, 43713-43722.
28. Wang,X. et al. (2003) A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res., 31, e154.
29. Yeudall,W.A. et al. (1994) MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis, 15, 2683-2686.
30. Wrighton,K.H. et al. (2004) Aberrant p53 alters DNA damage checkpoints in response to cisplatin: downregulation of CDK expression and activity. Int. J. Cancer, 112, 760-770.
31. Jakus,J. et al. (1996) Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. Oncogene, 12, 2369-2376.
32. Wonsey,D.R. et al. (2005) Loss of the forkhead transcription factor FOXM1 causes centrosome amplification and mitotic catastrophe. Cancer Res., 65, 5181-5189.
33. Dennis,G. et al. (2003) DAVID: database for annotation, visualization, and integrated discovery. Genome Biol., 4, P3.
34. Huang,D.W. et al. (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
35. Cardinali,M. et al. (1995) Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. Int. J. Cancer, 61, 98-103.
36. Christofakis,E.P. et al. (2008) Roles of CXCL8 in squamous cell carcinoma proliferation and migration. Oral Oncol., 44, 920-926.
37. Innocenti,M. et al. (2003) Phosphoinositide 3-kinase activates Rac by entering in a complex with Eps8, Abi1, and Sos-1. J. Cell Biol., 160, 17-23.
38. Wang,I.C. et al. (2008) Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors. Oncogene, 27, 4137-4149.
39. Costa,R.H. (2005) FOXM1 dances with mitosis. Nat. Cell Biol., 7, 108- 110.
40. Laoukili,J. et al. (2005) FOXM1 is required for execution of the mitotic programme and chromosome stability. Nat. Cell Biol., 7, 126-136.
41. Gemenetzidis,E. et al. (2009) FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS ONE, 4, e4849.
42. Miyazaki,H. et al. (2006) Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis. Oral Oncol., 42, 240-256.
43. Itoh,Y. et al. (2005) IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine, 29, 275-282.
44. Luppi,F. et al. (2007) Interleukin-8 stimulates cell proliferation in nonsmall cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer, 56, 25-33.
45. Metzner,B. et al. (1999) Overexpression of CXC-chemokines and CXCchemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431. Oncol. Rep., 6, 1405-1410.
46. Schraufstatter,I.U. et al. (2001) IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am. J. Physiol. Lung Cell. Mol. Physiol., 280, L1094-L1103.
47. Singh,S. et al. (2004) CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab. Invest., 84, 1666-1676.
48. Rehman,A.O. et al. (2008) SDF-1{alpha}promotes invasion of head and neck squamous cell carcinoma by activating NF-{kappa}B. J. Biol. Chem., 283, 19888-19894
49. Molinolo,A.A. et al. (2007) Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin. Cancer Res., 13, 4964-4973.
50. O-Charoenrat,P. et al. (2004) Signaling pathways required for matrix metalloproteinase-9 induction by betacellulin in head-and-neck squamous carcinoma cells. Int. J. Cancer, 111, 174-183.
51. Sodhi,A. et al. (2004) Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc. Natl Acad. Sci. USA, 101, 4821-4826.
52. Chandrasekar,B. et al. (2004) CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J. Biol. Chem., 279, 3188-3196.
53. Bonacchi,A. et al. (2001) Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J. Biol. Chem., 276, 9945-9954.
54. Limatola,C. et al. (2002) Signaling pathways activated by chemokine receptor CXCR2 and AMPA-type glutamate receptors and involvement in granule cells survival. J. Neuroimmunol., 123, 9-17.
55. Wang,J. et al. (2005) Diverse signaling pathways through the SDF-1/ CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. Cell. Signal., 17, 1578-1592.
56. Wang,J. et al. (2005) Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. Oncogene, 24, 5897-5904.
57. Wang,J. et al. (2008) The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J. Biol. Chem., 283, 4283-4294.
58. Li,Q. et al. (2009) Critical role and regulation of transcription factor FOXM1 in human gastric cancer angiogenesis and progression. Cancer Res., 69, 3501-3509.
59. Duffy,M.J. (2004) The urokinase plasminogen activator system: role in malignancy. Curr. Pharm. Des., 10, 39-49.
60. Dano,K. et al. (2005) Plasminogen activation and cancer. Thromb. Haemost., 93, 676-681.
61. Lester,R.D. et al. (2007) uPAR induces epithelial mesenchymal transition in hypoxic breast cancer cells. J. Cell Biol., 178, 425-436.
62. Dass,K. et al. (2008) Evolving role of uPA/uPAR system in human cancers. Cancer Treat. Rev., 34, 122-136.
63. Spence,H.J. et al. (2000) Krp1, a novel kelch related protein that is involved in pseudopod elongation in transformed cells. Oncogene, 19, 1266-1276.
64. Spence,H.J. et al. (2006) AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins. Mol. Cell. Biol., 26, 1480-1495.